I was wondering any thoughts on this statement by McGann on the CC about the proposed sale:
"And right now today, I'm telling you, we're going to have a great FY 2017 and we don’t have a great story on how we can reinvest those hard earned dollars. So we're trying to find ways to do that. If we end up selling the ETD business, it will be because it's the right thing to do for that business and the Board obviously would have to approve that and that process continues. Building a broader profile is one approach that has really never been looked at, not in my time anyway, and if this is successful, we could give our company the opportunity to actually do a capital raise and bring in new equity investors to help address the capital structure. "
It sounded to me that they might still be looking at an alternative to a sale of the ETD such as a capital raise?
Also tied into that what did he mean by this:
"Within the bigger we of Implant Sciences, this transaction gets culminated with the sale, that’s one thing, without a sale, we're still going forward. The point is is that we really want to build a new market around the Flyboard Air technology. So we have a good underpinning of a company that's great financials, great track record in terms of its growth. It's very good supply chain management, great manufacturing management that's based on Marseilles, France. "
How could they acquire Zapata without selling the ETD business or is this related to what he said as an alternative pursuing a capital raise to fund the Zapata deal and clean up the debt?
